| Heading: |
Medical Treatments: Innovation |
| Question ID: |
1826517 |
| UIN: |
HL9907 |
| House: |
Lords |
| Date tabled: |
2025-07-24 |
| Asking Member ID: |
2484 |
| Asking Member display name: |
Lord Rennard
|
| Asking Member handle: |
LordRennard
|
| Asking Member Twitter reference: |
@LordRennard
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government whether long-term clinical benefits and broader impacts, such as economic activity and emotional wellbeing, of medical innovations are routinely considered by the National Institute for Health and Care Excellence; and what |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-08-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) develops its guidance independently and on the basis of an assessment of the available evidence, taking into account all health-related costs and benefits for patients and caregivers, including ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |